(Q43031201)

12 November 2017

title

Study of the serological response after vaccination against tick-borne encephalitis in Sweden (English)

1 reference

12 November 2017

0 references

tick-borne encephalitis

1 reference

Sirkka Vene

1

1 reference

12 November 2017

Mats Haglund

2

1 reference

12 November 2017

Ake Lundkvist

3

1 reference

12 November 2017

Lars Lindquist

4

1 reference

12 November 2017

Marianne Forsgren

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

2 August 2006

1 reference

12 November 2017

1 reference

12 November 2017

volume

25

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

366-372

1 reference

Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Central european tick-borne encephalitis from 1969 to 1972 in central bohemia (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Spread of early-summer meningoencephalitis in the Federal Republic of Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959-1987.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Epidemiology of tick-borne encephalitis in Sweden 1956-1989: a study of 1116 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

TBE vaccination and the Austrian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

The Golden Agers and Tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

A rapid fluorescent focus inhibition test for detection of neutralizing antibodies to tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Characterisation of human tick‐borne encephalitis virus from Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Polio immunity to killed vaccine: an 18-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

Antibody response to gp E of tick-borne encephalitis virus: comparison between natural infection and vaccination breakdown

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.07.026

1 reference

12 November 2017

1 reference